Saudi Press

Saudi Arabia and the world
Monday, Feb 23, 2026

World Health Organisation warns countries not to treat Covid-19 patients with unproven medicine amid scramble for a cure

History of medicine abounds with ‘examples of drugs that worked on paper or in a test tube but were actually harmful’, WHO chief says. Warning comes as cases of the respiratory ailment caused by the coronavirus surge worldwide

The World Health Organisation (WHO) on Friday warned governments against treating infected coronavirus patients with medications not scientifically proven to fight the pathogen.

WHO Director General Tedros Adhanom Ghebreyesus issued the warning as cases of Covid-19, the respiratory ailment caused by the coronavirus that emerged in China late last year, surged worldwide, prompting health authorities to scramble to find treatments.

“We call on all individuals and countries to refrain from using therapeutics that have not been demonstrated to be effective in the treatment of Covid-19,” Tedros said. “The history of medicine is strewn with examples of drugs that worked on paper, or in a test tube, but didn't work in humans, or were actually harmful.”

“During the most recent Ebola epidemic, for example, some medicines that were thought to be effective were found not to be as effective as other medicines, when they were compared during a clinical trial,” he said. “We must follow the evidence. There are no short cuts.”

Tedros did not name any individuals, including US President Donald Trump, who came under criticism for touting chloroquine – a medicine for malaria – as a treatment for Covid-19 patients.

Trump defended his aim to start using the medicine regardless of the WHO warning.

Asked in a White House briefing about whether he would continue pushing chloroquine as a treatment, Trump said: “We have people dying now.”

“If we're going to go into labs and test all of this for a long time, we can test it on people right now who are in serious trouble who would dying,” Trump said. “If it works, we've done a great thing. If it doesn't work, you know, we tried.”

The US leader began pushing for chloroquine as a treatment last week.

In a press briefing on March 19, Trump, referring to the medication, said: “Normally the [US Food and Drug Administration] would take a long time to approve something like that, and it was approved very, very quickly and it's now approved, by prescription.”

Soon after Trump’s comments, the FDA said that chloroquine had not been approved for treating Covid-19 and that more tests were needed to determine its safety and effectiveness.

A day later, US infectious disease expert Dr. Anthony Fauci said evidence that chloroquine worked against Sars-CoV-2, the scientific name for the new coronavirus, was “anecdotal”.

The effort to prove the medication’s efficacy against the contagion, he said, “was not done in a controlled clinical trial, so you really can’t make any definitive statement about it”.

Many US media outlets have reported shortages of chloroquine and hydroxychloroquine, a newer derivative of chloroquine that is also used for malaria, since Covid-19 cases began to surge in the country.

Tedros also warned that “off-label” usage of medication – the prescribing of sanctioned drugs for other, unapproved purposes – to treat Covid-19 potentially threatens the health of many individuals not infected with the new illness.

“We need to ensure that using unproven drugs does not create a shortage of those medicines to treat diseases for which they have proven effective,” the head of the UN agency said in the briefing.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
United States Approves Over Fifteen Billion Dollars in Major Arms Sales to Israel and Saudi Arabia
Pre-Iftar Walks Gain Momentum as Ramadan Wellness Trend Spreads
Middle East Jackup Rig Fleet Contracts Further After Saudi Drilling Suspensions
Türkiye and Saudi Arabia Prepare to Sign Five Gigawatt Renewable Energy Deal at COP31
King Mohammed VI Congratulates Saudi Leadership on Founding Day, Reaffirming Strategic Ties
US Envoy Huckabee Clarifies Remarks on Israel After Expansionism Controversy
Saudi Arabia Introduces Limited Exceptions to Regional Headquarters Requirement for Foreign Firms
Saudi Arabia Joins Global Partnership on Artificial Intelligence, Elevating Its Role in Shaping AI Governance
Saudi Arabia and Arab States Mobilise Diplomatically After U.S. Envoy’s Israel Remarks
Cristiano Ronaldo Reaffirms His Commitment to Saudi Arabia Amid Transfer Speculation
Proposed US-Saudi Nuclear Deal Raises Questions Over Uranium Enrichment Provisions
Saudi Arabia Sends 81st Aid Flight to Gaza as Humanitarian Air Bridge Continues
Global Games Show Riyadh 2026 Positioned as Catalyst for Saudi Arabia’s Vision 2030
Saudi Arabia Eases Procurement Rules, Allowing Foreign Firms Greater Access to Government Contracts
Türkiye and Saudi Arabia Seal Two Billion Dollar Solar Energy Agreement
Saudi Crown Prince Reportedly Sends Letter to UAE Leader Over Yemen and Sudan Policies
Saudi Arabia Voices Concerns to UAE Over Sudan Conflict and Yemen Strategy
Saudi Arabia Joins Global Artificial Intelligence Alliance to Strengthen International Collaboration
Shura Island Positioned as Flagship of Saudi Arabia’s Ambitious Red Sea Tourism Drive
Saudi Arabia Rebukes Mike Huckabee Over Remarks in Tucker Carlson Interview
OpenAI CEO Sam Altman praises the rapid progress of Chinese tech companies.
Concerns Mount Over Potential Saudi Uranium Enrichment in Prospective US Nuclear Accord
Trump Directs Government to Release UFO and Alien Information
Trump Signs Global 10% Tariffs on Imports
Investability Emerges as the Defining Test of Saudi Arabia’s Next Market Phase
Saudi Arabia’s Packaging Market Accelerates as Sustainability and E-Commerce Drive Transformation
Saudi Arabia’s Strategic Minerals Drive Offers Lessons for Europe’s Supply Chain Ambitions
Saudi Arabia Unveils $32 Billion Push Into Theme Parks and Global Entertainment
Saudi Crude Exports to India Climb Sharply, Closing Gap With Russia
Saudi Arabia’s Halal Cosmetics Market Expands as Faith and Ethical Beauty Drive Growth
United Kingdom Denies U.S. Access to Military Base for Potential Iran Strike
ImmunityBio Secures Saudi Partnerships to Launch Flagship Cancer Therapy
Türkiye and Saudi Arabia Launch Expanded Renewable Energy Partnership
US Supreme Court Voids Trump’s Emergency Tariff Plan, Reshaping Trade Power and Fiscal Risk
UK Intensifies Efforts to Secure Saudi Investment in Next-Generation Fighter Jet Programme
Saudi Arabia Tops Middle East Green Building Rankings with Record Growth in 2025
Qatar and Saudi Arabia Each Commit One Billion Dollars to President Trump’s ‘Board of Peace’ Initiative
Ramadan 2026 Prayer Times Set as Fasting Begins in Saudi Arabia and Egypt Announces Dates
Saudi Arabia Launches Ramadan 2026 Hotel Campaign to Boost Religious and Leisure Tourism
Saudi Arabia Seeks Reroute of Greece-Bound Fibre-Optic Cable Through Syria Instead of Israel
Saudi-Backed Scopely Acquires Majority Stake in Turkey’s Loom Games to Expand Mobile Portfolio
Zodiac Milpro Launches Zid Marine Joint Venture in Saudi Arabia to Expand Regional Shipbuilding
Saudi Arabia Reaffirms Reform Path Amid Claims of Ideological Reversal
Calls Grow for Saudi Arabia and UAE to Settle Differences Through Direct Dialogue
Jensen Huang just told the story of how Elon Musk became NVIDIA’s very first customer for their powerful AI supercomputer
British couple sentenced to 10 years in Iran for espionage
Former British Prince Andrew Arrested on Suspicion of Misconduct in Public Office
Unitree Robotics founder Wang Xingxing showcases future robot deployment during Spring Festival Gala.
Prince William Holds Talks with Crown Prince Mohammed bin Salman During Saudi Visit
Saudi Arabia’s Humain Commits $3 Billion Investment to Elon Musk’s xAI
×